Librela®

Go To Manufacturer's Website

This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors.

How it works

and dosing information

Monthly Arthritis Pain Control

Librela® is a once-monthly injection used to control pain associated with osteoarthritis in dogs.

Unlike an NSAID, Librela® is a monoclonal antibody. It targets nerve growth factor (NGF), a protein involved in transmitting arthritis pain signals.

How is Librela® given?

Librela® is given under the skin once a month at our clinic.

Some dogs may show improvement after their first injection, while others may require a second monthly injection before a noticeable response is seen.

What does Librela® do?

Librela® helps control the pain associated with arthritis, which may improve your dog's comfort and mobility.

It is important to understand that Librela® controls arthritis pain but does not slow or reverse the progression of arthritis itself.

Because dogs may feel better and suddenly become more active, activity should be increased gradually to help prevent injury.

Is Librela® right for every dog?

Not necessarily. We will consider your dog's age, medical history, current medications, mobility, and neurologic and urinary history before recommending Librela®.

Librela® should not be used in dogs under 12 months of age or in dogs that are pregnant, nursing, or intended for breeding.

Potential adverse effects have been reported, including changes in balance or walking, weakness, difficulty standing, seizures, increased drinking or urination, urinary incontinence, vomiting, and diarrhea. Serious adverse reactions have also been reported.

We recommend discussing the benefits and risks with our veterinary team to determine whether Librela® is appropriate for your dog.

More information: https://www.zoetisus.com/products/dogs/librela/